Clin2
NCT07060547Possibly a fitRecruiting

Blood test for alcohol-related liver disease

Alcoholic HepatitisAlcohol-related Liver Disease

Part of Digestive system clinical trials.

This study tests a new blood test (HepQuant DuO) to see how well it measures liver function in people with alcohol-related liver disease. If you have liver damage from alcohol and either a recent serious liver flare-up or also a fatty liver condition (NASH), this study may help your doctors understand your liver better.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
40 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are 18 years or older.
  • You have been told by a doctor that you have liver disease caused by alcohol.
  • You either have a sudden worsening of your liver function (acute decompensation), or you also have a fatty liver condition not related to alcohol (NASH).
  • You do not have any other cause of liver disease like autoimmune hepatitis, drug injury, hemochromatosis, or Wilson's disease.
  • You have not had a solid organ cancer (like lung, breast, or colon).
  • You are not pregnant.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04088370Recruiting
Testing blood immune cell response in alcohol-related liver disease

This study looks at how immune cells in the blood respond in people with alcoholic hepatitis and in people who drink heavily (with no known liver disease). It may help researchers understand why liver inflammation happens after heavy alcohol use.

Cleveland, Ohio
NCT05623150Recruiting
Biopsy-based study for alcohol and metabolic liver disease

This trial studies people with liver disease linked to alcohol use or metabolic syndrome (a cluster of conditions like weight gain and insulin resistance). It uses recent standard-of-care liver biopsy results to better understand these chronic liver problems and how they relate to cancer risk.

Nice
NCT07473817Not yet recruiting
Testing a new way to collect blood samples for liver function

This trial tests a simpler blood collection method for measuring liver function using a substance you drink. It includes healthy people and those with chronic liver disease (like F2-F3 fibrosis or cirrhosis) to see if the new method works as well as standard procedures.

NCT06493773Recruiting
Alcohol help for new liver disease diagnosis

This trial tests a program to help people recently diagnosed with alcohol-related liver disease cut back on drinking. If you qualify, you may get support to improve your liver health.

Køge, Køge
NCT04400604Recruiting
Study of liver disease risk from heavy alcohol use

This study looks at people with heavy alcohol use who may have alcohol-related liver damage. It aims to better understand liver disease risk and how it changes over time, using blood tests, some scans, and possibly stored tissue.

Lille
NCT06747364Recruiting
Blood test for recent alcohol use

This study looks at a blood test that may tell how much alcohol a person has had recently, even after they've stopped drinking. It may help doctors better understand drinking patterns and health risks.

Denton, Texas

Hear when a new Alcoholic Hepatitis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.